About the 21st IMS Annual Meeting

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects. This year’s program includes:

Six thematic sessions on: Precursor Disease, Newly Diagnosed, High Risk Disease, Relapsed: Treatments Outside of Immunotherapy, Immunotherapy, Novel Biomarkers - personalizing therapy in myeloma

* Talks and symposia on pressing topics led by the KOL of the myeloma community
* Special Sessions for trainees and local attendees
* Keynote addresses
* Joint sessions with regulatory agencies and other organisations
* Special sessions on MRD and New Endpoints
* Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies)
* Poster Presentations